Phase I study of muscadine grape extract in advanced malignancy.

Rhonda L. Bitting,Janet A. Tooze,William J. Petty,Stefan C. Grant,Rodwige J. Desnoyers,Alexandra Thomas,Christopher Y. Thomas,Angela Tatiana Alistar,Shannon Golden,Katherine Pleasant,E. Ann Tallant,Patricia E. Gallagher,Heidi D. Klepin

Phase I study of muscadine grape extract in advanced malignancy.

2018

Rhonda L. Bitting
Janet A. Tooze
William J. Petty
Stefan C. Grant
Rodwige J. Desnoyers
Alexandra Thomas
Christopher Y. Thomas
Angela Tatiana Alistar
Shannon Golden
Katherine Pleasant
E. Ann Tallant
Patricia E. Gallagher
Heidi D. Klepin

e14548Background: Preclinical studies with muscadine grape extract (MGE) show anti-tumor activity and decreased systemic inflammation. This phase I study (NCT02583269) assessed safety and tolerabil...

Keywords:

Pathology
Grape extract
Malignancy
Medicine
phase i study
Pharmacology
Systemic inflammation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations